This study aims to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition
January 19, 2024
First Patients Enrolled in the Gore VBX Forward Clinical Study
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore…
Read More
Sumeet Chugh, MD, shown at work in his Cedars-Sinai laboratory
January 19, 2024
Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award
January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-…
Read More
Abbott's Volt PFA System is designed to overcome limitations of first-generation PFA systems by providing physicians a clearer indication of contact between the Volt PFA Catheter and targeted tissue
January 18, 2024
Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed…
Read More
First in-man experience exceeds expectations, cited as “game changer” for below-the-knee procedures
January 18, 2024
Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for…
Read More
The American Heart Association has issued a new Policy Statement focused on the need to address structural racism as a central component to reducing cardiovascular disparities across the United States.
January 18, 2024
American Heart Association New Policy Statement: Addressing Structural Racism Central to Reducing U.S. Cardiovascular Disease Disparities
January 18, 2024 — A new American Heart Association (AHA) policy statement examines the history of structural racism,…
Read More
Physician-researcher David Ouyang, MD, to bring longstanding expertise to Journal focused on artificial intelligence and machine learning
January 17, 2024
Smidt Heart Institute Expert Named Deputy Editor of NEJM AI
January 17, 2024 — One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has…
Read More
The application of AI technology in the diagnosis of cardiovascular diseases using coronary CT angiography (CCTA) has gradually deepened
January 17, 2024
Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine
January 17, 2024 — This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling…
Read More
Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
January 16, 2024
Cardiac Dimensions Appoints Satya Shreenivas, MD, as Chief Medical Officer
January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment…
Read More
Pilot program to deploy highly portable technology to be rolled out later this year 
January 16, 2024
Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease
January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same…
Read More
Latest technology combines superior catheter design and sustained aspiration to maximize blood clot removal from the coronary vasculature
January 16, 2024
Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome
January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its…
Read More
A public-private partnership Think Tank
January 15, 2024
Cardiac Safety Research Consortium Announces Think Tank Program with FDA Regulators, Industry and Academia Focused on Cardiac Remote Monitoring Trials and AI
January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the…
Read More
Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.
January 15, 2024
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis
January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the …
Read More
Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.
January 15, 2024
Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke
January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been …
Read More
Webinar addresses driving efficiency while maintaining diagnostic performance.
January 15, 2024
SPONSORED CONTENT: Webinar on Applying SMART-CT Results to Daily Clinical Practice
HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis…
Read More
ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)
January 12, 2024
BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine
January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and…
Read More
An unprecedented collaboration between an eminent heart surgeon, a Michelin-starred chef and a global cardiovascular device provider sees the launch of a unique, surgically inspired recipe book, conceived to help surgeons practice their surgical dexterity in an unexpected way
January 12, 2024
A World-first Collaboration to Help Heart Surgeons Utilize Their Dexterity in an Unexpected Way – Introducing The Heart Surgeon’s Cookbook
January 12, 2024 — The Heart Surgeon’s Cookbook is the brainchild of New York-based Cardiovascular and Thoracic Surgeon…
Read More
January 11, 2024
WEBINAR NOW AVAILABLE ON DEMAND: Contrast Management in Modern PCI
On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on  "Contrast Management in Modern PCI…
Read More
It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS
January 11, 2024
In Memoriam: Bruce Wilkoff, MD, FHRS
January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned…
Read More
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients
January 11, 2024
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study
January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the…
Read More
The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups.
January 11, 2024
Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors
January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now